Task: Answer the multiple choice question.
Question: Which drug exhibits a 10.501% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. COc1ccc(CCNC(=O)C(NC(=O)OCc2ccccc2)C(C)C)cc1OC
b. CCCn1c(SCc2csc(-c3ccccc3)n2)nc2ccccc2c1=O
Answer: b. CCCn1c(SCc2csc(-c3ccccc3)n2)nc2ccccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(SCc2csc(-c3ccccc3)n2)nc2ccccc2c1=O
CCCn1c(SCc2csc(-c3ccccc3)n2)nc2ccccc2c1=O
2-[(2-phenyl-1,3-thiazol-4-yl)methylsulfanyl]-3-propylquinazolin-4-one